Graf Akcie ICCC (Immucell Corp.). Diskuze k akciím ICCC. Aktuální informace ICCC.

Základní informace o společnosti Immucell Corp. (Akcie ICCC)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 71.79M
Hodnota podniku (EV) 73.98M
Tržby 16.115M
EBITDA 1.411M
Zisk -434.25
Růst v tržbách Q/Q 53.13 %
Růst v tržbách Y/Y 11.30 %
P/E (Cena vůči ziskům) N/A
Forward P/E -107.25
EV/Sales 4.59
EV/EBITDA 52.43
EV/EBIT N/A
PEG N/A
Price/Sales 4.25
P/FCF N/A
Price/Book 2.42
Účetní hodnota na akcii 3.83
Hotovost na akcii 1.08
FCF vůči ceně -4.87 %
Počet zaměstnanců 59
Tržba na zaměstnance 273.133k
Profit margin -6.66 %
Operating margin -6.49 %
Gross margin 44.73 %
EBIT margin -2.67 %
EBITDA margin 8.76 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok N/A %
Return on assets -1.06 %
Return on equity -1.49 %
ROIC -2.61 %
ROCE -1.03 %
Dluhy/Equity 0.43
Čistý dluh/EBITDA 6.92
Current ratio 7.64
Quick Ratio 6.45
Volatilita 6.02
Beta 0.51
RSI 48.72
Cílová cena analytiků 14
Známka akcie (dle analytiků) N/A
Insider ownership 28.62 %
Institutional ownership 10.19 %
Počet akcií 7.742M
Procento shortovaných akcií 0.19 %
Short ratio 0.93 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1987
Země United States

Finanční výsledky akcie ICCC

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$13.723$10.986$10.431$9.544$10.229$7.597
Cost Of Goods Sold$6.983$5.792$5.21$4.123$3.978$3.148
Gross Profit$6.74$5.194$5.221$5.421$6.251$4.449
Research And Development Expenses------
SG&A Expenses$7.694$7.341$5.464$4.531$4.129$4.655
Other Operating Income Or Expenses-$0.7----
Operating Expenses$14.677$12.433$10.674$8.654$8.106$7.803
Operating Income$-0.954$-1.447$-0.243$0.89$2.122$-0.206
Total Non-Operating Income/Expense$-0.314$-0.414$-0.196$-0.132$-0.059$-0.049
Pre-Tax Income$-1.267$-1.86$-0.439$0.758$2.064$-0.256
Income Taxes$0.028$0.462$-0.27$0.25$0.85$-0.088
Income After Taxes$-1.296$-2.322$-0.168$0.508$1.213$-0.167
Other Income------
Income From Continuous Operations$-1.296$-2.322$-0.168$0.508$1.213$-0.167
Income From Discontinued Operations------
Net Income$-1.296$-2.322$-0.168$0.508$1.213$-0.167
EBITDA$1.331$0.091$0.662$1.693$2.648$0.243
EBIT$-0.954$-1.447$-0.243$0.89$2.122$-0.206
Basic Shares Outstanding755433
Shares Outstanding755433
Basic EPS$-0.19$-0.42$-0.03$0.12$0.40$-0.06
EPS - Earnings Per Share$-0.19$-0.42$-0.03$0.12$0.38$-0.06
# 2020 2019 2018 2017 2016 2015
Current Ratio5.28542.50323.63726.96899.93725.4215
Long-term Debt / Capital0.19780.27920.2680.12740.22350.0746
Debt/Equity Ratio0.29050.44910.37960.15270.30020.0968
Gross Margin49.11347.276250.055756.797161.111558.5641
Operating Margin-6.9512-13.167-2.32819.327420.7487-2.7169
EBIT Margin-6.9512-13.167-2.32819.327420.7487-2.7169
EBITDA Margin9.69540.8286.342517.734625.89033.1924
Pre-Tax Profit Margin-9.2358-16.9306-4.20367.945620.1741-3.3626
Net Profit Margin-9.4411-21.1324-1.6125.327411.8611-2.2004
Asset Turnover0.35470.33570.30410.38640.70350.6874
Inventory Turnover Ratio2.7732.48422.54171.93864.57113.3284
Receiveable Turnover8.382111.78417.76119.617114.2447.5569
Days Sales In Receivables43.545230.973947.029437.95325.624848.3003
ROE - Return On Equity-4.4689-10.6771-0.71262.578111.4308-1.8055
Return On Tangible Equity-4.5015-10.7909-0.72022.613511.4308-1.8055
ROA - Return On Assets-3.3485-7.0932-0.49022.05878.344-1.5125
ROI - Return On Investment-3.5851-7.6964-0.52162.24978.876-1.6709
Book Value Per Share4.01933.90454.30884.06893.47423.0586
Operating Cash Flow Per Share0.1023-0.30570.2889-0.96740.8162-0.2562
Free Cash Flow Per Share0.28872.9494-2.4707-0.94930.4855-0.5698